Neupravičene presaditve ledvic

Citat:
Uporabnik krnekejjeto pravi:

Citat:
Povej se kaksno o neupravicenih presaditvah ledvic ker baje po tvoje ljudi zanalasc dializirajo ko se ena od obeh ledvic "deluje".

Klikni za razširitev

No Blacky zdej pa povej kje sem to napisal....
Dokaži!

Klikni za razširitev

https://www.alter.si/tabla/showflat.php/Cat/0/Number/870384/page/0/fpart/1/vc/1
post st:
#919110 - 25.04.2010 18:38

Realityjevi kriteriji za transplantacijo ledvic.

Za v anale zgodovine.

Citat:
Uporabnik krnekejjeto pravi:
Dej citat, kjer sem to napisal, kar praviš "ker baje po tvoje ljudi zanalasc dializirajo ko se ena od obeh ledvic "deluje".

Še enkrat citat...
prosim....

Klikni za razširitev

Imas oznaceno stevilko posta. Ze stara tema kjer si dokazal le svoje frustracije in populisticno nabijanje, brez poznavanja golih osnov.

Zmeraj kot te kdo postavi pred argumentirana dejstva se hitro "vadis" na zaljivke, korupcijo, tvoje facte in ostalo kramo. Ker ti pac "poznas kranjske Junkije" in njihovo cepljenje Energix B bomo pac tebi verjeli na temo hepatitisa.

Daj zresni se.

cepljenje proti hepatitisu B ni 100% zaščita.razsikave kažejo da je zaščita uspešna pri 85-90% ljudi kar je še vedno veliko več kot 0% a se strinjaš?

Torej govoriš o enem primeru? Vau, to pa je vzorec za potegnit zaključke....

Citat:
Uporabnik krnekejjeto pravi:
blaki.... najdem post, ki še zmeraj ne piše kar flancaš ti... kašna dializa...
a si čorov...

kr se tiče junkijev.. pejt stavit, pa da bo pošteno dava ves denar junkiju. Ps bomo pogledali kartoteko, da je bil cepljen in da ima hep B....
Da ne boš u prazno mlatil....
Mislim, pa da je bil dotični tudi enkrat v prispevku RTVja, sam se žal ne spomnim ime oddaje.
Imena ne bom povedal, ke bi blo to nekorektno.

Drgač pa bleki, dej citat v katerm piše

Citat:
ker baje po tvoje ljudi zanalasc dializirajo ko se ena od obeh ledvic

Klikni za razširitev

da vidimo tvoje razumevanje anale...

Verjamem, da bo zopet tvoj post obstal mojga bojo brisal... ker bleki vse ve..........

ovca od moderatorja pa se strinja z njim.

Klikni za razširitev

Evo tvoj veleum:

Citat:
Aha statistično povej še kok ledvic se prime in denarno kok stanejo zdravila proti zavrnitvi...

In ponavadi, da smo realni, so na prednosti tisti, kateri imajo odpoved obeh ledvic in ne ene in ja še zmeraj ostajajo na dializi...

samo zavajanje te je... Kako ravnajo s temi bolniki pa je šokantno, niti za prevoz nimajo in kakšna je čakanje na ta prevoz... brezveze govort, se obnašaš kot bi živel v Švice....

Klikni za razširitev

In se da ti takoj odgovorim tukaj na sveze, glede nato da je v sloveniji minila 40 obletnica transplatacije ledvic.

Prime se 99% ledvic. 10 letno prezivetje (delovanja) presadka je blizu 80% kar je v samem svetovnem vrhu.

Citat:
Uporabnik krnekejjeto pravi:
Ne nasprotno primerov je več med junkiji z hep B in so bili v otroštvu v fazi obveznega cepljenja...
Za enega pa vem, da bi proti plačilu to tudi dokazov z zdr. kartoteko...

vau pokaži študijo cepljenih, ki so jih namerno okuževali, šele na podlagi tega boš dobu učinkovitost cepljenja, vse prej je kvakanje na pamet.


druga stvar zavajanje, ki ga sedaj tala ena koza na privat ordinaciji v priponki... Zavajanje, da glava boli, seveda z podpisom se starši odpovedo tožbi zoper stranskih učinkov cepiva...

Klikni za razširitev

Da pocistimo tvoje populisticne floskule o neresnosti hepatitisa:

Hepatitis B

Fact sheet N°204
July 2012

Key facts

Hepatitis B is a viral infection that attacks the liver and can cause both acute and chronic disease.
The virus is transmitted through contact with the blood or other body fluids of an infected person.
Two billion people worldwide have been infected with the virus and about 600 000 people die every year due to the consequences of hepatitis B.
The hepatitis B virus is 50 to 100 times more infectious than HIV.
Hepatitis B is an important occupational hazard for health workers.
Hepatitis B is preventable with the currently available safe and effective vaccine.
Hepatitis B is a potentially life-threatening liver infection caused by the hepatitis B virus. It is a major global health problem and the most serious type of viral hepatitis. It can cause chronic liver disease and puts people at high risk of death from cirrhosis of the liver and liver cancer.

Worldwide, an estimated two billion people have been infected with the hepatitis B virus and more than 240 million have chronic (long-term) liver infections. About 600 000 people die every year due to the acute or chronic consequences of hepatitis B.

A vaccine against hepatitis B has been available since 1982. Hepatitis B vaccine is 95% effective in preventing infection and its chronic consequences, and is the first vaccine against a major human cancer.

Who is at risk for chronic disease?
The likelihood that infection with the hepatitis B virus becomes chronic depends upon the age at which a person becomes infected. Young children who become infected with the hepatitis B virus are the most likely to develop chronic infections:

90% of infants infected during the first year of life develop chronic infections;
30–50% of children infected between one to four years of age develop chronic infections.
In adults:

25% of adults who become chronically infected during childhood die from hepatitis B-related liver cancer or cirrhosis;
90% of healthy adults who are infected with the hepatitis B virus will recover and be completely rid of the virus within six months.

Prevention

The hepatitis B vaccine is the mainstay of hepatitis B prevention. WHO recommends that all infants receive the hepatitis B vaccine.

The vaccine can be given as either three or four separate doses, as part of existing routine immunization schedules. In areas where mother-to-infant spread of the hepatitis B virus is common, the first dose of vaccine should be given as soon as possible after birth (i.e. within 24 hours).

The complete vaccine series induces protective antibody levels in more than 95% of infants, children and young adults. Protection lasts at least 20 years and is possibly lifelong.

All children and adolescents younger than 18 years old and not previously vaccinated should receive the vaccine. People in high risk groups should also be vaccinated, including:

people with high-risk sexual behaviour
partners and household contacts of infected people
injecting drug users
people who frequently require blood or blood products
recipients of solid organ transplantation
people at occupational risk of hepatitis B virus infection, including health-care workers
travellers to countries with high rates of hepatitis B.
The vaccine has an outstanding record of safety and effectiveness. Since 1982, over one billion doses of hepatitis B vaccine have been used worldwide. In many countries, where 8–15% of children used to become chronically infected with the hepatitis B virus, vaccination has reduced the rate of chronic infection to less than 1% among immunized children.

As of July 2011, 179 countries vaccinate infants against hepatitis B as part of their vaccination schedules – a major increase compared with 31 countries in 1992, the year that the World Health Assembly passed a resolution to recommend global vaccination against hepatitis B.